Scientific support for gene therapy research
Ended Awarded Last action
- Contract number
- 75F40121F19068
- Awardee
-
Midnight Sun Technologies LLC UEI ZKR5F6EZNAD2 Part of Midnight Sun Aus, LLC
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $263,361
Award facts
- Contract value 100% obligated
- $263,360.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Available for Competition Only One Source
- Pricing
- Labor Hours
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$6,006 | |
| Exercise an Option | $136,402 | |
| Other Administrative Action | $0 | |
| Original award | $132,965 |
About this award
This federal contract award is for scientific support services related to gene therapy research, awarded by the Food and Drug Administration (FDA) to Midnight Sun Technologies LLC, a subsidiary of Kikiktagruk Inupiat Corporation (KIC), an Alaska Native Corporation. The $263,360.64 Delivery Order contract, which has a completion date of September 15, 2023, does not utilize any set-aside designation.
Midnight Sun Technologies is an 8(a) Program participant, Indian Economic Enterprise, and Small Disadvantaged Business that specializes in providing scientific, technical, and business support services to federal agencies, primarily the Department of Health and Human Services (HHS), FDA, and National Institutes of Health (NIH). The company has expertise in areas such as immunology, gene therapy, stem cell research, and plasma protein therapies, and has supported the FDA's Generic Drug Program and research on pandemic influenza potency assays.
In addition to this specific contract, Midnight Sun Technologies holds several Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $200 million multiple-award IDIQ contract with the Department of the Interior Bureau of Indian Affairs for Business Support Services, and two single-award IDVs with the FDA for scientific support services, each valued at $25 million.
Quick answers
Who was awarded contract 75F40121F19068?
75F40121F19068 was awarded to Midnight Sun Technologies LLC by Food and Drug Administration (Department of Health and Human Services) on June 17, 2021.
How much is contract 75F40121F19068 worth?
The government has obligated $263,361 on 75F40121F19068.
Is contract 75F40121F19068 an order under another contract?
Yes. 75F40121F19068 is a delivery order under 75F40119D10015, an indefinite delivery contract.
Was contract 75F40121F19068 competed?
The extent of competition for 75F40121F19068 was not available for competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award